These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30950072)

  • 1. Preclinical imaging of epidermal growth factor receptor with ABY-029 in soft-tissue sarcoma for fluorescence-guided surgery and tumor detection.
    Samkoe KS; Sardar HS; Bates BD; Tselepidakis NN; Gunn JR; Hoffer-Hawlik KA; Feldwisch J; Pogue BW; Paulsen KD; Henderson ER
    J Surg Oncol; 2019 Jun; 119(8):1077-1086. PubMed ID: 30950072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Suitable Untargeted Agent for the Clinical Translation of ABY-029 Paired-Agent Imaging in Fluorescence-Guided Surgery.
    Wang C; Xu X; Hodge S; Chen EY; Hoopes PJ; Tichauer KM; Samkoe KS
    Mol Imaging Biol; 2023 Feb; 25(1):97-109. PubMed ID: 34642897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-agent fluorescent labeling of soft-tissue sarcomas improves the contrast based upon targeting both interstitial and cellular components of the tumor milieu.
    Sardar HS; Zai Q; Xu X; Gunn JR; Pogue BW; Paulsen KD; Henderson ER; Samkoe KS
    J Surg Oncol; 2020 Dec; 122(8):1711-1720. PubMed ID: 32885452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Discrimination of Tumors with Low and Heterogeneous EGFR Expression in Fluorescence-Guided Surgery Through Paired-Agent Protocols.
    Wang C; Xu X; Folaron M; Gunn JR; Hodge S; Chen EY; Hoopes PJ; Tichauer KM; Samkoe KS
    Mol Imaging Biol; 2023 Feb; 25(1):110-121. PubMed ID: 34651290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection.
    Samkoe KS; Sardar HS; Gunn J; Feldwisch J; Linos K; Henderson E; Pogue B; Paulsen K
    Proc SPIE Int Soc Opt Eng; 2019 Feb; 10862():. PubMed ID: 31595101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paired-agent imaging for detection of head and neck cancers.
    Samkoe KS; Park Y; Marra K; Chen EY; Tichauer KM
    Proc SPIE Int Soc Opt Eng; 2019 Feb; 10853():. PubMed ID: 31686720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant Therapies Do Not Reduce Epidermal Growth Factor Receptor (EGFR) Expression or EGFR-Targeted Fluorescence in a Murine Model of Soft-Tissue Sarcomas.
    Streeter SS; Xu X; Hebert KA; Werth PM; Hoopes PJ; Jarvis LA; Pogue BW; Paulsen KD; Samkoe KS; Henderson ER
    Mol Imaging Biol; 2024 Apr; 26(2):272-283. PubMed ID: 38151580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use.
    Samkoe KS; Gunn JR; Marra K; Hull SM; Moodie KL; Feldwisch J; Strong TV; Draney DR; Hoopes PJ; Roberts DW; Paulsen K; Pogue BW
    Mol Imaging Biol; 2017 Aug; 19(4):512-521. PubMed ID: 27909986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions.
    de Souza AL; Marra K; Gunn J; Samkoe KS; Hoopes PJ; Feldwisch J; Paulsen KD; Pogue BW
    Mol Imaging Biol; 2017 Feb; 19(1):41-48. PubMed ID: 27379987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
    Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
    Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
    Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
    Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing Glioma Detection Using an EGFR-Targeted Fluorescent Affibody.
    Ribeiro de Souza AL; Marra K; Gunn J; Samkoe KS; Hull S; Paulsen KD; Pogue BW
    Photochem Photobiol; 2018 Nov; 94(6):1167-1171. PubMed ID: 30129069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence-Guided Visualization of Soft-Tissue Sarcomas by Targeting Vascular Endothelial Growth Factor A: A Phase 1 Single-Center Clinical Trial.
    Steinkamp PJ; Pranger BK; Li MF; Linssen MD; Voskuil FJ; Been LB; van Leeuwen BL; Suurmeijer AJH; Nagengast WB; Kruijff S; van Ginkel RJ; van Dam GM
    J Nucl Med; 2021 Mar; 62(3):342-347. PubMed ID: 32680922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of a connective tissue phantom model for subsurface visualization of cancers requiring wide local excision.
    Samkoe KS; Bates BD; Tselepidakis NN; DSouza AV; Gunn JR; Ramkumar DB; Paulsen KD; Pogue BW; Henderson ER
    J Biomed Opt; 2017 Dec; 22(12):1-12. PubMed ID: 29274143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative Detection of Micrometastases in Whole Excised Lymph Nodes Using Fluorescent Paired-Agent Imaging Principles: Identification of a Suitable Staining and Rinsing Protocol.
    Li C; Torres VC; He Y; Xu X; Basheer Y; Papavasiliou G; Samkoe KS; Brankov JG; Tichauer KM
    Mol Imaging Biol; 2021 Aug; 23(4):537-549. PubMed ID: 33591478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying Imaging Agent Binding and Dissociation in 3-D Cancer Spheroid Tissue Culture Using Paired-Agent Principles.
    Li C; Rounds CC; Torres VC; He Y; Xu X; Papavasiliou G; Samkoe KS; Brankov JG; Tichauer KM
    Ann Biomed Eng; 2024 Jun; 52(6):1625-1637. PubMed ID: 38409434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery.
    Kijanka M; Warnders FJ; El Khattabi M; Lub-de Hooge M; van Dam GM; Ntziachristos V; de Vries L; Oliveira S; van Bergen En Henegouwen PM
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1718-29. PubMed ID: 23778558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence Lifetime-Based Tumor Contrast Enhancement Using an EGFR Antibody-Labeled Near-Infrared Fluorophore.
    Pal R; Kang H; Choi HS; Kumar ATN
    Clin Cancer Res; 2019 Nov; 25(22):6653-6661. PubMed ID: 31481509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Fluorescence-Guided Surgery to Subsurface Cancers Requiring Wide Local Excision: Literature Review and Novel Developments Toward Indirect Visualization.
    Samkoe KS; Bates BD; Elliott JT; LaRochelle E; Gunn JR; Marra K; Feldwisch J; Ramkumar DB; Bauer DF; Paulsen KD; Pogue BW; Henderson ER
    Cancer Control; 2018; 25(1):1073274817752332. PubMed ID: 29334791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on the Phase 0 clinical trial of microdose administration of ABY-029 for fluorescence guided surgery: Stability testing.
    Samkoe KS; Hull S; Elliott J; Sardar HS; Gunn J; Linos K; Tafe L; Harris B; Feldwisch J; Pogue BW; Roberts D; Henderson E; Paydarfar J; Paulsen K
    Proc SPIE Int Soc Opt Eng; 2020 Feb; 11222():. PubMed ID: 36051445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.